GlassScriptPhysician profile
Sara Romani
NPI 1336928845
$597.43
in general payments reported to CMS, 2019-2025
16 companies · $597 in 2025
The $597 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $113.93 | 2025 | Breztri, Airsupra |
| Novo Nordisk INC | $60.71 | 2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $58.13 | 2025 | |
| Novartis Pharmaceuticals Corporation | $55.38 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $49.97 | 2025 | Opsynvi, Uptravi |
| Dexcom, INC. | $40.22 | 2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $40.13 | 2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.66 | 2025 | Jardiance |
| Baxter Healthcare | $23.93 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $22.04 | 2025 | Eliquis |
| Alk-Abello, INC | $20.55 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $18.78 | 2025 | Shingrix, Arexvy |
| Alexion Pharmaceuticals, INC. | $18.72 | 2025 | Strensiq |
| Bayer Healthcare Pharmaceuticals INC. | $17.61 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $17.17 | 2025 | Rexulti |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.50 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Romani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.